Novel diagnostics may be a cost-effective intervention for sepsis management to reduce bed days and reduce inappropriate prescribing of antibiotics.
Sepsis is a life-threatening condition in response to infection. Without rapid treatment, sepsis can result in tissue damage, organ failure or death. Speed is of the essence for sepsis management and faster diagnosis of specific pathogens may help ensure patients receive the most appropriate treatments as soon as possible. Reducing the use of broad-spectrum antibiotics Read More >
Further evidence that point of care (POC) testing for STIs means better clinical care for patients
Most people are now familiar with using rapid diagnostic tests with many people regularly using lateral flow tests for COVID-19. Within sexual health clinics, rapid testing for HIV has been widely used for a number of years but using rapid tests for other sexually transmitted infections (STIs) such as chlamydia and gonorrhoea is not yet Read More >
Sexual Health
Improving clinical decision making and patient management
How much would community-based screening for chlamydia and gonorrhoea cost?
We collaborated with St George’s, University of London, on a NIHR-funded study ‘Test n Treat’ (TnT). This study assessed the cost of providing same-day chlamydia and gonorrhoea testing and treatment service at higher education colleges. The paper presenting this work was published in BMC Health Services Research and is now available online. Read More >
Could a same day test and treatment service in further education colleges improve uptake of chlamydia testing among young people?
Aquarius were part of a recent feasibility trial looking at whether provision of a same day test and treatment service for chlamydia in further education colleges increased uptake of chlamydia testing and treatment. The results of the trial were published this week in Clinical Microbiology and Infection and are available online. Read More >
Evaluating multi-bug point-of-care tests for diagnosing STIs
New point-of-care (POC) tests are currently being developed which can be used in clinic to simultaneously test for multiple sexually transmitted infections (STIs). In work now published online in BMJ Open, we developed a model to compare three possible strategies for POC STI testing with the current practice of microscopy and lab-based testing. The three Read More >
A rapid testing service for chlamydia and gonorrhoea yields significant patient and public health benefits
Aquarius Population Health, a leading independent health economics consultancy, worked with Chelsea and Westminster NHS Foundation Trust to assess the impact of Dean Street Express, their award winning sexual health clinic in Soho, London. This service tests symptom-free people wanting a routine sexual health check-up using an on-site 90-minute chlamydia and gonorrhoea rapid test. They Read More >
PRESS RELEASE: Aquarius Population Health wins a prestigious SBRI grant from Innovate UK
Work has begun to develop a digital value proposition tool for a novel rapid sexually transmitted infection (STI) test London, UK, 14 August 2017 Aquarius Population Health, a leading independent health economics consultancy, has recently been awarded an 18-month Innovate UK grant in collaboration with Atlas Genetics Ltd and the Applied Diagnostic Research and Evaluation Read More >
Evaluating the use AMR POCT in treatment of gonorrhoea
Aquarius Population Health recently worked with the Applied Diagnostic Research & Evaluation Unit (ADREU) at St. Georges, University of London, to assess the cost-effectiveness of six hypothetical strategies for using antimicrobial resistance point-of-care testing to guide the treatment of gonorrhoea. Our findings were presented at the STI & HIV World Congress in Rio de Janeiro, Read More >
Evaluating multi-bug point-of-care tests for sexually transmitted infections
We were a collaborator on a recent Innovate UK-funded SBRI project with Binx and the Applied Diagnostic Research and Evaluation Unit at St George’s University of London. In this project, our team compared the overall costs, patient benefits and cost-effectiveness of three different multi-pathogen point-of-care testing strategies with the current strategy of microscopy and lab-based Read More >